Role of metalloproteinases MMP-2 in asthma

La Tunisie Medicale
|January 5, 2017
PubMed

Insights

This study investigated the MMP-2 gene polymorphism (-735C/T) and its link to asthma. Researchers found no association between this specific genetic variation and asthma susceptibility or severity in the studied population.

Area of Science:

  • Genetics
  • Respiratory Medicine
  • Molecular Biology

Background:

  • Metalloproteinases (MMPs) are implicated in asthma pathogenesis.
  • Matrix metalloproteinase-9 (MMP-9) is prominent in asthma, but other MMPs, like MMP-2, are also involved.

Purpose of the Study:

  • To investigate the association between the MMP2 gene single nucleotide polymorphism (SNP) at the -735C/T position and asthma susceptibility.
  • To determine if this MMP2 polymorphism influences asthma severity.

Main Methods:

  • A case-control study design was employed, enrolling 150 asthma patients and 150 healthy controls.
  • Genotyping for the MMP2 -735C/T polymorphism was performed using polymerase chain reaction and restriction fragment length polymorphism analysis.

Main Results:

  • No statistically significant association was found between the MMP2 -735C/T polymorphism (both allele and genotype frequencies) and asthma susceptibility.
  • The study also found no correlation between the MMP2 -735C/T polymorphism and the severity of asthma.

Conclusions:

  • The role of MMP-2 in asthma pathogenesis remains uncertain.
  • This study did not establish a link between the MMP2 -735C/T gene polymorphism and asthma, highlighting the need for further research.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.1K
The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
12.9K